Literature DB >> 17008481

IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?

A B Millar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17008481      PMCID： PMC2104749          DOI： 10.1136/thx.2006.060772

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  23 in total

Review 1.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung.

Authors:  K Nakagome; M Dohi; K Okunishi; R Tanaka; J Miyazaki; K Yamamoto
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

Review 3.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis.

Authors:  R Bingisser; R Speich; A Zollinger; E Russi; K Frei
Journal:  Respiration       Date:  2000       Impact factor: 3.580

5.  Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages.

Authors:  S Lim; G Caramori; K Tomita; E Jazrawi; T Oates; K F Chung; P J Barnes; I M Adcock
Journal:  Allergy       Date:  2004-05       Impact factor: 13.146

Review 6.  The role of transforming growth factor beta in lung development and disease.

Authors:  Ulrike Bartram; Christian P Speer
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

7.  A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Kevin K Brown; Williamson Z Bradford; Karen Starko; Paul W Noble; David A Schwartz; Talmadge E King
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

8.  Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

Authors:  Juan J Gómez-Reino; Loreto Carmona; Vicente Rodríguez Valverde; Emilio Martín Mola; Maria Dolores Montero
Journal:  Arthritis Rheum       Date:  2003-08

Review 9.  Anti-cytokine therapy in fibrosing alveolitis: where are we now?

Authors:  A Millar
Journal:  Respir Res       Date:  2000-06-20

10.  Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis.

Authors:  Atsushi Kitani; Ivan Fuss; Kazuhiko Nakamura; Fumiyuki Kumaki; Takashi Usui; Warren Strober
Journal:  J Exp Med       Date:  2003-10-13       Impact factor: 14.307
View more
  4 in total

1.  Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.

Authors:  Ayodeji Adegunsoye; Justin M Oldham; Catherine Bonham; Cara Hrusch; Paul Nolan; Wesley Klejch; Shashi Bellam; Uday Mehta; Kiran Thakrar; Janelle Vu Pugashetti; Aliya N Husain; Steven M Montner; Christopher M Straus; Rekha Vij; Anne I Sperling; Imre Noth; Mary E Strek; Jonathan H Chung
Journal:  Am J Respir Crit Care Med       Date:  2019-03-15       Impact factor: 21.405

Review 2.  Pulmonary fibrosis: pathogenesis, etiology and regulation.

Authors:  M S Wilson; T A Wynn
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

3.  Network Pharmacology-Based Mechanistic Investigation of Jinshui Huanxian Formula Acting on Idiopathic Pulmonary Fibrosis.

Authors:  Tiantian Liu; Pengli Xu; Shuishui Qi; Shaorui Ke; Qin Hu; Peng Zhao; Jiansheng Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-07       Impact factor: 2.629

4.  The role of Interleukin-10 and 13 in tuberculosis-associated pulmonary dysfunction.

Authors:  Mohammad Hasan Namaei; Sayyed-Gholamreza Mortazavi-Moghaddam; Reza Eslami-Manoochehri; Eslami-Manoochehri Zardast
Journal:  Caspian J Intern Med       Date:  2019
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.